Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Public ClinicalTrials.gov record NCT00097071. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in the United States of America (USA). It is demonstrated that intensive insulin therapy resulting in good glycaemic control can reduce or delay the incidence of complications secondary to Type 1 Diabetes. Insulin Aspart (NovoLog®) is an ideal insulin to use in an intensive insulin regimen using continuous subcutaneous insulin injection (CSII) therapy in the pediatric and adolescent age population. This trial compares the safety and efficacy of Insulin Aspart (NovoLog®) and Insulin Lispro (Humalog®) delivered by CSII in children and adolescents with type 1 diabetes.
Study identification
- NCT ID
- NCT00097071
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 299 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 3 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2004 (Type not available)
- Primary completion
- May 2006 (Actual)
- Completion
- May 2006 (Actual)
- Last update posted
- Dec 22, 2016
2004 – 2006
United States locations
- U.S. sites
- 52
- U.S. states
- 32
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Mobile | Alabama | 36617 | — |
| Novo Nordisk Investigational Site | Montgomery | Alabama | 36106 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85016 | — |
| Novo Nordisk Investigational Site | Little Rock | Arkansas | 72202 | — |
| Novo Nordisk Investigational Site | Loma Linda | California | 92354 | — |
| Novo Nordisk Investigational Site | Sacramento | California | 95816 | — |
| Novo Nordisk Investigational Site | San Diego | California | 92123 | — |
| Novo Nordisk Investigational Site | Denver | Colorado | 80262 | — |
| Novo Nordisk Investigational Site | Englewood | Colorado | 80110 | — |
| Novo Nordisk Investigational Site | New Haven | Connecticut | 06520 | — |
| Novo Nordisk Investigational Site | Orlando | Florida | 32806-1101 | — |
| Novo Nordisk Investigational Site | St. Petersburg | Florida | 33701 | — |
| Novo Nordisk Investigational Site | Tallahassee | Florida | 32308 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30318 | — |
| Novo Nordisk Investigational Site | Idaho Falls | Idaho | 83404-7596 | — |
| Novo Nordisk Investigational Site | Indianapolis | Indiana | 46202-2879 | — |
| Novo Nordisk Investigational Site | Iowa City | Iowa | 52242 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Wichita | Kansas | 67226 | — |
| Novo Nordisk Investigational Site | Baton Rouge | Louisiana | 70808 | — |
| Novo Nordisk Investigational Site | Baltimore | Maryland | 21229 | — |
| Novo Nordisk Investigational Site | Baltimore | Maryland | 21287 | — |
| Novo Nordisk Investigational Site | Boston | Massachusetts | 02115 | — |
| Novo Nordisk Investigational Site | Boston | Massachusetts | 02215 | — |
| Novo Nordisk Investigational Site | Springfield | Massachusetts | 01107 | — |
| Novo Nordisk Investigational Site | Worcester | Massachusetts | 01655 | — |
| Novo Nordisk Investigational Site | Detroit | Michigan | 48202-2689 | — |
| Novo Nordisk Investigational Site | Minneapolis | Minnesota | 55416 | — |
| Novo Nordisk Investigational Site | Minneapolis | Minnesota | 55455 | — |
| Novo Nordisk Investigational Site | Kansas City | Missouri | 64108 | — |
| Novo Nordisk Investigational Site | Omaha | Nebraska | 68114 | — |
| Novo Nordisk Investigational Site | Omaha | Nebraska | 68198-3020 | — |
| Novo Nordisk Investigational Site | Hackensack | New Jersey | 07601 | — |
| Novo Nordisk Investigational Site | Brooklyn | New York | 11219 | — |
| Novo Nordisk Investigational Site | Buffalo | New York | 14222 | — |
| Novo Nordisk Investigational Site | Manhasset | New York | 11030 | — |
| Novo Nordisk Investigational Site | The Bronx | New York | 10467 | — |
| Novo Nordisk Investigational Site | Asheville | North Carolina | 28803 | — |
| Novo Nordisk Investigational Site | Chapel Hill | North Carolina | 27599-7220 | — |
| Novo Nordisk Investigational Site | Columbus | Ohio | 43203 | — |
| Novo Nordisk Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Novo Nordisk Investigational Site | Portland | Oregon | 97239 | — |
| Novo Nordisk Investigational Site | Hershey | Pennsylvania | 17033 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Novo Nordisk Investigational Site | Pittsburgh | Pennsylvania | 15224 | — |
| Novo Nordisk Investigational Site | Charleston | South Carolina | 29425 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78284 | — |
| Novo Nordisk Investigational Site | Norfolk | Virginia | 23507 | — |
| Novo Nordisk Investigational Site | Seattle | Washington | 98105 | — |
| Novo Nordisk Investigational Site | Charleston | West Virginia | 25302 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53226-0509 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00097071, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2016 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00097071 live on ClinicalTrials.gov.